MEG/MRS Dose Response Study of STX209 in ASD
Project Description:
The major goal of this project is to assess the electrophysiologic activity, and begin to develop stratifying variables as predictors of change, of a short-term course of Arbaclofen (STX209) for children with ASD. Role: Co-Investigator, Study Physician
Core Function(s):
Training Trainees, Performing Research or Evaluation, Continuing Education/Community Training
Area of Emphasis
Child Care-Related Activities, Health-Related Activities
Target Audience:
Professionals and Para-Professionals, Family Members/Caregivers
Unserved or Under-served Populations:
None
Primary Target Audience Geographic Descriptor:
Not Applicable
COVID-19 Related Data:
N/A